Olga V. Kotelnikova

Miklukho Maklaya St. 16/10
Moscow, MOW 117997, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Protective Antimicrobial Effect of the Potential Vaccine Created on the Basis of the Structure of the IgA1 Protease from Neisseria meningitidis.

Protective Antimicrobial Effect of the Potential Vaccine Created on the Basis of the Structure of the IgA1 Protease from Neisseria meningitidis.

Journal: Vaccines

Published: September 23, 2024

Highly Similar Sequences of Mature IgA1 Proteases from Neisseria meningitidis, Neisseria gonorrhoeae and Haemophilus influenzae.

Highly Similar Sequences of Mature IgA1 Proteases from Neisseria meningitidis, Neisseria gonorrhoeae and Haemophilus influenzae.

Journal: Pathogens (Basel, Switzerland)

Published: May 20, 2022

Correction to: Specific Antibodies to the Fragments of Meningococcal IgA1 Protease during the Formation of Immunity to Bacterial Infections.

Correction to: Specific Antibodies to the Fragments of Meningococcal IgA1 Protease during the Formation of Immunity to Bacterial Infections.

Journal: Bulletin of experimental biology and medicine

Published: February 08, 2022

Specific Antibodies to the Fragments of Meningococcal IgA1 Protease during the Formation of Immunity to Bacterial Infections.

Specific Antibodies to the Fragments of Meningococcal IgA1 Protease during the Formation of Immunity to Bacterial Infections.

Journal: Bulletin of experimental biology and medicine

Published: February 08, 2022

Protective potency of recombinant meningococcal IgA1 protease and its structural derivatives upon animal invasion with meningococcal and pneumococcal infections.

Protective potency of recombinant meningococcal IgA1 protease and its structural derivatives upon animal invasion with meningococcal and pneumococcal infections.

Journal: Microbes and infection

Published: June 20, 2018

Peculiarities of the Formation of Antimeningococcus Immunity in Mice Immunized with Fragments of N. meningitidis IgA1 Protease.

Peculiarities of the Formation of Antimeningococcus Immunity in Mice Immunized with Fragments of N. meningitidis IgA1 Protease.

Journal: Bulletin of experimental biology and medicine

Published: December 26, 2017

Serological Analysis of Immunogenic Properties of Recombinant Meningococcus IgA1 Protease-Based Proteins.

Serological Analysis of Immunogenic Properties of Recombinant Meningococcus IgA1 Protease-Based Proteins.

Journal: Bulletin of experimental biology and medicine

Published: September 16, 2015

A new methodological approach to estimation of IgA1 and IgA2 content in human serum using recombinant IgA1 protease from Neisseria meningitidis.

A new methodological approach to estimation of IgA1 and IgA2 content in human serum using recombinant IgA1 protease from Neisseria meningitidis.

Journal: Biotechnology letters

Published: April 28, 2015

Protective properties of recombinant IgA1 protease from meningococcus

Protective properties of recombinant IgA1 protease from meningococcus

Journal: Biomeditsinskaia khimiia

Published: September 25, 2014

Protective properties of synthetic peptides of outer meningococcal membrane.

Protective properties of synthetic peptides of outer meningococcal membrane.

Journal: Bulletin of experimental biology and medicine

Published: October 15, 2005

Showing 1-10 of 10

Last Updated: 09/26/2026